Lucy Gladman General Manager BHRUT Lung MDT Large Acute Trust 1 - - PowerPoint PPT Presentation

lucy gladman general manager bhrut
SMART_READER_LITE
LIVE PREVIEW

Lucy Gladman General Manager BHRUT Lung MDT Large Acute Trust 1 - - PowerPoint PPT Presentation

Lung Cancer MDT Project BHRUT Lucy Gladman General Manager BHRUT Lung MDT Large Acute Trust 1 st April 2014 31 st March 2015* Population ~ 750,000 303 primary patients diagnosed 306 patients discussed at MDT


slide-1
SLIDE 1

Lung Cancer MDT Project BHRUT Lucy Gladman – General Manager

slide-2
SLIDE 2

BHRUT

Large Acute Trust

Population ~ 750,000

Treat 10% of London's cancers; 50% of NEL’s cancers

Financially challenged

Special measures since January 2014

Lung MDT

1st April 2014 – 31st March 2015*

303 primary patients diagnosed

306 patients discussed at MDT

203 treatments

 37 monitoring  44 chemo  6 chemo radiotherapy  39 palliative care  50 surgery  27 radiotherapy 

Staging completeness Jan – Dec 2014 – 89%**

* Somerset, ** COSD

slide-3
SLIDE 3

Project Objectives

 To establish baseline metrics;  To redesign and implement an MDT model that meets

the requirements of the London Cancer pathway specification;

 To devise a plan for monitoring and evaluating the

effectiveness of the redesigned MDT;

 To measure and evaluate the impact and effectiveness

  • f the revised MDT model and ensure alignment with

national best practice;

 To use the intelligence gained to develop a “blue print”

model and recommendations for wider implementation.

slide-4
SLIDE 4

Project Support

 Two partnered Trusts to pool expertise;  Supported by Medical and Educational Grant

from Pfizer;

 Project manager appointed from Quintiles;  Lead Clinician for Cancer;  Lung MDT Clinical Lead;  Service Manager for Respiratory;  General Manager for Cancer.

slide-5
SLIDE 5

Baseline Data

Top priority KPIs:

Time from referral to DTT;

Number of patients who go on to treatment;

Number of patients who go on to be enrolled in clinical trials;

Additional KIPs

Number of new patients per MDT;

MDT attendance;

Time from referral to diagnosis;

Time from referral to staging;

Time from staging to DTT MDT;

Proportion of patients to:

 Surgery  Chemotherapy  Palliative intervention.

slide-6
SLIDE 6

Project Timeline

slide-7
SLIDE 7

Workshop

 7th January 2015;  23 attendees

– Physicians, Surgeon, CNS’s, MDT Coordinators,

Hisptopathologist, Oncologist, Palliative Care, Radiologist, Managers

 17 high level actions identified;  Three overarching themes:

 MDT  2WW  Surgery

slide-8
SLIDE 8

Actions Identified

 Excessive workload of the lung cancer MDT

and need for lung nodule MDT;

 CT scan required prior to first OPA;  Optimise days for EBUS;  Increased lung function capacity required  PET scanner needed;  Communication between Trusts  Improved data

slide-9
SLIDE 9

Actions Implemented

 Nodule MDT;

– Protocol written; – Budget identified for admin support; – Advertised and interviewed 27th May. – Start date TBA!

 To pilot nurse-led nodule service;

– Business case to be developed

slide-10
SLIDE 10

Actions Implemented

 CT scan prior to first OPA;  Previous implementation put 2ww target at

risk;

 Audit undertaken of 2 weeks of 2ww referrals;

– Understand actual demand – Try to establish protocol for Cancer Referrals Office

 Meeting held with radiology for them to

understand MDT requirement;

 Need to identify area for CT hydration patients

slide-11
SLIDE 11

Actions Implemented

 Excessive workload of MDT;  Audit undertaken of delayed patients due to

unavailability of notes at MDT;

 Nodule MDT will move some workload;  Inter-MDT process refined;  EBUS moved to Wednesday;

– Reduces number of patients not discussed at MDT;

 Review MDT Coordinator support;

– Pool work across site; – Band 3 support to coordinate MDT agenda

slide-12
SLIDE 12

Actions Implemented

 Enabling works for PET scanner;

– Awaiting financial approval;

 Need business case to increase lung function

test capacity;

 Meeting with Bart’s Health – 4th June 2015, to

improve communications;

 MDT received training on how to improve data

quality for NLCA;

 Review MDT once all actions implemented.

slide-13
SLIDE 13

Summary

 Identified short, medium and long term actions;  Brought team together;  Focused the actions needed;  Raised profile of cancer targets with the

clinicians;

 Identified audits to be undertaken;  Project overran;

– Restructure; – CQC re-visit

 Committed to keeping up the actions.

slide-14
SLIDE 14

“If there is no struggle, there is no progress.” Frederick Douglass